SNPs in toll-like receptor (TLR) genes as new genetic alterations associated with congenital toxoplasmosis?

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 32, Issue 4, 2013, Pages 503-511

  Wujcicka, W ^a   Wilczynski J ^a   Nowakowska, D ^a  

^a POLISH MOTHER S MEMORIAL HOSPITAL RESEARCH INSTITUTE   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 9;

ADAPTIVE IMMUNITY; ARTICLE; CONGENITAL TOXOPLASMOSIS; DISEASE ASSOCIATION; DNA MODIFICATION; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; HUMAN; INFECTION RISK; INNATE IMMUNITY; MOLECULAR PATHOLOGY; NONHUMAN; PREGNANCY; PREGNANCY DISORDER; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TOLL LIKE RECEPTOR 2 GENE; TOLL LIKE RECEPTOR 4 GENE; TOLL LIKE RECEPTOR 9 GENE; TOXOPLASMA GONDII;

FEMALE; HUMANS; INFANT, NEWBORN; MODELS, BIOLOGICAL; POLYMORPHISM, SINGLE NUCLEOTIDE; PREGNANCY; TOLL-LIKE RECEPTORS; TOXOPLASMA; TOXOPLASMOSIS, CONGENITAL;

EID: 84879461638     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1763-y     Document Type: Article

References (66)

1. Nowakowska D, Colón I, Remington JS, Grigg M, Golab E, Wilczyński J, Sibley LD (2006) Genotyping of Toxoplasma gondii by multiplex PCR and peptide-based serological testing of samples from infants in Poland diagnosed with congenital toxoplasmosis. J Clin Microbiol 44(4):1382-1389
2. Berrebi A, Bardou M, Bessieres MH, Nowakowska D, Castagno R, Rolland M, Wallon M, Franck J, Bongain A, Monnier-Barbarino P, Assouline C, Cassaing S (2007) Outcome for children infected with congenital toxoplasmosis in the first trimester and with normal ultrasound findings: a study of 36 cases. Eur J Obstet Gynecol Reprod Biol 135(1):53-57 (Pubitemid 350026157)
3. Jamieson SE, de Roubaix LA, Cortina-Borja M, Tan HK, Mui EJ, Cordell HJ, Kirisits MJ, Miller EN, Peacock CS, Hargrave AC, Coyne JJ, Boyer K, Bessieres MH, Buffolano W, Ferret N, Franck J, Kieffer F, Meier P, Nowakowska DE, Paul M, Peyron F, Stray-Pedersen B, Prusa AR, Thulliez P, Wallon M, Petersen E, McLeod R, Gilbert RE, Blackwell JM (2008) Genetic and epigenetic factors at COL2A1 and ABCA4 influence clinical outcome in congenital toxoplasmosis. PLoS One 3(6):e2285
4. Nowakowska D, Stray-Pedersen B, Spiewak E, Sobala W, Małafiej E, Wilczyński J (2006) Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population. Clin Microbiol Infect 12(9):913-917 (Pubitemid 44151293)
5. Nowakowska D, Respondek-Liberska M, Golab E, Stray-Pedersen B, Szaflik K, Dzbenski TH, Wilczynski J (2005) Too late prenatal diagnosis of fetal toxoplasmosis: a case report. Fetal Diagn Ther 20(3):190-193 (Pubitemid 40591547)
6. Rajendran C, Su C, Dubey JP (2012) Molecular genotyping of Toxoplasma gondii from Central and South America revealed high diversity within and between populations. Infect Genet Evol 12(2):359-368
7. Howe DK, Sibley LD (1995) Toxoplasma gondii comprises three clonal lineages: correlation of parasite genotype with human disease. J Infect Dis 172:1561-1566
8. Switaj K, Master A, Skrzypczak M, Zaborowski P (2005) Recent trends in molecular diagnostics for Toxoplasma gondii infections. Clin Microbiol Infect 11(3):170-176 (Pubitemid 40352762)
9. Nathan CF, Murray HW, Wiebe ME, Rubin BY (1983) Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity. J Exp Med 158(3):670-689 (Pubitemid 13051337)
10. Suzuki Y, Orellana MA, Schreiber RD, Remington JS (1988) Interferon-gamma: the major mediator of resistance against Toxoplasma gondii. Science 240(4851):516-518
11. Pifer R, Yarovinsky F (2011) Innate responses to Toxoplasma gondii in mice and humans. Trends Parasitol 27(9):388-393
12. Denkers EY, Butcher BA, Del Rio L, Bennouna S (2004) Neutrophils, dendritic cells and Toxoplasma. Int J Parasitol 34(3):411-421 (Pubitemid 38299190)
13. Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny S, Sutterwala FS, Flavell RA, Ghosh S, Sher A (2005) TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science 308(5728):1626-1629 (Pubitemid 40807512)
14. Yarovinsky F (2008) Toll-like receptors and their role in host resistance to Toxoplasma gondii. Immunol Lett 119(1-2):17-21
15. Roach JC, Glusman G, Rowen L, Kaur A, Purcell MK, Smith KD, Hood LE, Aderem A (2005) The evolution of vertebrate Toll-like receptors. Proc Natl Acad Sci U S A 102(27):9577-9582 (Pubitemid 40981723)
16. McBerry C, Gonzalez RM, Shryock N, Dias A, Aliberti J (2012) SOCS2-induced proteasome-dependent TRAF6 degradation: a common anti-inflammatory pathway for control of innate immune responses. PLoS One 7(6):e38384
17. Liu CH, Machado FS, Guo R, Nichols KE, Burks AW, Aliberti JC, Zhong XP (2007) Diacylglycerol kinase zeta regulates microbial recognition and host resistance to Toxoplasma gondii. J Exp Med 204(4):781-792 (Pubitemid 46631608)
18. Hou B, Benson A, Kuzmich L, DeFranco AL, Yarovinsky F (2011) Critical coordination of innate immune defense against Toxoplasma gondii by dendritic cells responding via their Toll-like receptors. Proc Natl Acad Sci U S A 108(1):278-283
19. Bierly AL, Shufesky WJ, Sukhumavasi W, Morelli AE, Denkers EY (2008) Dendritic cells expressing plasmacytoid marker PDCA-1 are Trojan horses during Toxoplasma gondii infection. J Immunol 181(12):8485-8491
20. Sukhumavasi W, Egan CE, Warren AL, Taylor GA, Fox BA, Bzik DJ, Denkers EY (2008) TLR adaptor MyD88 is essential for pathogen control during oral Toxoplasma gondii infection but not adaptive immunity induced by a vaccine strain of the parasite. J Immunol 181(5):3464-3473
21. Melo MB, Kasperkovitz P, Cerny A, Könen-Waisman S, Kurt-Jones EA, Lien E, Beutler B, Howard JC, Golenbock DT, Gazzinelli RT (2010) UNC93B1 mediates host resistance to infection with Toxoplasma gondii. PLoS Pathog 6(8):e1001071
22. Virta M, Pessi T, Helminen M, Seiskari T, Kondrashova A, Knip M, Hyöty H, Hurme M (2008) Interaction between CD14-159C>T polymorphism and Helicobacter pylori is associated with serum total immunoglobulin E. Clin Exp Allergy 38(12):1929-1934
23. Jones LA, Anthony JP, Henriquez FL, Lyons RE, Nickdel MB, Carter KC, Alexander J, Roberts CW (2008) Toll-like receptor-4-mediated macrophage activation is differentially regulated by progesterone via the glucocorticoid and progesterone receptors. Immunology 125(1):59-69
24. Debierre-Grockiego F, Campos MA, Azzouz N, Schmidt J, Bieker U, Resende MG, Mansur DS, Weingart R, Schmidt RR, Golenbock DT, Gazzinelli RT, Schwarz RT (2007) Activation of TLR2 and TLR4 by glycosylphosphatidylinositols derived from Toxoplasma gondii. J Immunol 179(2):1129-1137
25. Benson A, Pifer R, Behrendt CL, Hooper LV, Yarovinsky F (2009) Gut commensal bacteria direct a protective immune response against Toxoplasma gondii. Cell Host Microbe 6(2):187-196
26. Minns LA, Menard LC, Foureau DM, Darche S, Ronet C, Mielcarz DW, Buzoni-Gatel D, Kasper LH (2006) TLR9 is required for the gut-associated lymphoid tissue response following oral infection of Toxoplasma gondii. J Immunol 176(12):7589-7597 (Pubitemid 43853053)
27. Degrandi D, Hoffmann R, Beuter-Gunia C, Pfeffer K (2009) The proinflammatory cytokine-induced IRG1 protein associates with mitochondria. J Interferon Cytokine Res 29(1):55-67
28. Mun HS, Aosai F, Norose K, Chen M, Piao LX, Takeuchi O, Akira S, Ishikura H, Yano A (2003) TLR2 as an essential molecule for protective immunity against Toxoplasma gondii infection. Int Immunol 15(9):1081-1087 (Pubitemid 37063207)
29. Scharton-Kersten TM, Yap G, Magram J, Sher A (1997) Inducible nitric oxide is essential for host control of persistent but not acute infection with the intracellular pathogen Toxoplasma gondii. J Exp Med 185(7):1261-1273 (Pubitemid 27172907)
30. Del Rio L, Butcher BA, Bennouna S, Hieny S, Sher A, Denkers EY (2004) Toxoplasma gondii triggers myeloid differentiation factor 88-dependent IL-12 and chemokine ligand 2 (monocyte chemoattractant protein 1) responses using distinct parasite molecules and host receptors. J Immunol 172(11):6954-6960 (Pubitemid 38669135)
31. Makino M, Uemura N, Moroda M, Kikumura A, Piao LX, Mohamed RM, Aosai F (2011) Innate immunity in DNA vaccine with Toxoplasma gondii-heat shock protein 70 gene that induces DC activation and Th1 polarization. Vaccine 29(10):1899-1905
32. Heimesaat MM, Fischer A, Jahn HK, Niebergall J, Freudenberg M, Blaut M, Liesenfeld O, Schumann RR, Göbel UB, Bereswill S (2007) Exacerbation of murine ileitis by Toll-like receptor 4 mediated sensing of lipopolysaccharide from commensal Escherichia coli. Gut 56(7):941-948 (Pubitemid 46999077)
33. Denkers EY (2009) A gut feeling for microbes: getting it going between a parasite and its host. Cell Host Microbe 6(2):104-106
34. Schatz F, Kayisli UA, Vatandaslar E, Ocak N, Guller S, Abrahams VM, Krikun G, Lockwood CJ (2012) Toll-like receptor 4 expression in decidual cells and interstitial trophoblasts across human pregnancy. Am J Reprod Immunol 68(2):146-153
35. Gillaux C, Méhats C, Vaiman D, Cabrol D, Breuiller-Fouché M (2011) Functional screening of TLRs in human amniotic epithelial cells. J Immunol 187(5):2766-2774
36. Mitsunari M, Yoshida S, Shoji T, Tsukihara S, Iwabe T, Harada T, Terakawa N (2006) Macrophage-activating lipopeptide-2 induces cyclooxygenase-2 and prostaglandin E(2) via toll-like receptor 2 in human placental trophoblast cells. J Reprod Immunol 72(1-2):46-59 (Pubitemid 44692307)
37. Abrahams VM, Bole-Aldo P, Kim YM, Straszewski-Chavez SL, Chaiworapongsa T, Romero R, Mor G (2004) Divergent trophoblast responses to bacterial products mediated by TLRs. J Immunol 173:4286-4296 (Pubitemid 39280656)
38. Patni S, Wynen LP, Seager AL, Morgan G, White JO, Thornton CA (2009) Expression and activity of Toll-like receptors 1-9 in the human term placenta and changes associated with labor at term. Biol Reprod 80(2):243-248
39. Riley JK, Nelson DM (2010) Toll-like receptors in pregnancy disorders and placental dysfunction. Clin Rev Allergy Immunol 39(3):185-193
40. Koga K, Mor G (2010) Toll-like receptors at the maternal-fetal interface in normal pregnancy and pregnancy disorders. Am J Reprod Immunol 63(6):587-600
41. Rose JA, Rabenold JJ, Parast MM, Milstone DS, Abrahams VM, Riley JK (2011) Peptidoglycan induces necrosis and regulates cytokine production in murine trophoblast stem cells. Am J Reprod Immunol 66(3):209-222
42. Klaffenbach D, Friedrich D, Strick R, Strissel PL, Beckmann MW, Rascher W, Gessner A, Dötsch J, Meissner U, Schnare M (2011) Contribution of different placental cells to the expression and stimulation of antimicrobial proteins (AMPs). Placenta 32(11):830-837
43. Negishi M, Izumi Y, Aleemuzzaman S, Inaba N, Hayakawa S (2011) Lipopolysaccharide (LPS)-induced Interferon (IFN)-gamma production by decidual mononuclear cells (DMNC) is interleukin (IL)-2 and IL-12 dependent. Am J Reprod Immunol 65(1):20-27
44. Abrahams VM, Fahey JV, Schaefer TM, Wright JA, Wira CR, Mor G (2005) Stimulation of first trimester trophoblast cells with Poly(I:C) induces SLPI secretion. Am J Reprod Immunol 53:280
45. Beijar EC, Mallard C, Powell TL (2006) Expression and subcellular localization of TLR-4 in term and first trimester human placenta. Placenta 27(2-3):322-326 (Pubitemid 41763474)
46. Gonzalez JM, Xu H, Ofori E, Elovitz MA (2007) Toll-like receptors in the uterus, cervix, and placenta: is pregnancy an immunosuppressed state? Am J Obstet Gynecol 197(3):296.e1-296.e6 (Pubitemid 47361964)
47. Xie F, Hu Y, Speert DP, Turvey SE, Peng G, Money DM, Magee LA, von Dadelszen P; Toxaemia Study Group (2010) Toll-like receptor gene polymorphisms and preeclampsia risk: a case-control study and data synthesis. Hypertens Pregnancy 29(4):390-398
48. Pereyra S, Velazquez T, Bertoni B, Sapiro R (2012) Rapid multiplex high resolution melting method to analyze inflammatory related SNPs in preterm birth. BMC Res Notes 5:69
49. Peixoto-Rangel AL, Miller EN, Castellucci L, Jamieson SE, Peixe RG, Elias Lde S, Correa-Oliveira R, Bahia-Oliveira LM, Blackwell JM (2009) Candidate gene analysis of ocular toxoplasmosis in Brazil: evidence for a role for toll-like receptor 9 (TLR9). Mem Inst Oswaldo Cruz 104(8):1187-1190
50. Liu J, Rädler D, Illi S, Klucker E, Turan E, von Mutius E, Kabesch M, Schaub B (2011) TLR2 polymorphisms influence neonatal regulatory T cells depending on maternal atopy. Allergy 66:1020-1029
51. Verstraelen H, Verhelst R, Nuytinck L, Roelens K, De Meester E, De Vos D, Van Thielen M, Rossau R, Delva W, De Backer E, Vaneechoutte M, Temmerman M (2009) Gene polymorphisms of Toll-like and related recognition receptors in relation to the vaginal carriage of Gardnerella vaginalis and Atopobium vaginae. J Reprod Immunol 79(2):163-173
52. Ryckman KK, Williams SM, Krohn MA, Simhan HN (2009) Genetic association of Toll-like receptor 4 with cervical cytokine concentrations during pregnancy. Genes Immun 10(7):636-640
53. Härtel Ch, Finas D, Ahrens P, Kattner E, Schaible T, Müller D, Segerer H, Albrecht K, Möller J, Diedrich K, Göpel W; Genetic Factors in Neonatology Study Group (2004) Polymorphisms of genes involved in innate immunity: association with preterm delivery. Mol Hum Reprod 10(12):911-915 (Pubitemid 40045314)
54. Łukaszewski T, Barlik M, Seremak-Mrozikiewicz A, Kurzawińska G, Mrozikiewicz PM, Sieroszewski P, Drews K (2009) Polymorphism in the genes of Toll-like receptors type 2 and type 4 (TLR-2 and TLR-4) and the risk of premature rupture of the membranes - preliminary study. Ginekol Pol 80(12):914-919
55. Krediet TG, Wiertsema SP, Vossers MJ, Hoeks SB, Fleer A, Ruven HJ, Rijkers GT (2007) Toll-like receptor 2 polymorphism is associated with preterm birth. Pediatr Res 62(4):474-476 (Pubitemid 47476208)
56. Rey G, Skowronek F, Alciaturi J, Alonso J, Bertoni B, Sapiro R (2008) Toll receptor 4 Asp299Gly polymorphism and its association with preterm birth and premature rupture of membranes in a South American population. Mol Hum Reprod 14(9):555-559
57. Lavoie PM, Ladd M, Hirschfeld AF, Huusko J, Mahlman M, Speert DP, Hallman M, Lacaze-Masmonteil T, Turvey SE (2012) Influence of common non-synonymous Toll-like receptor 4 polymorphisms on bronchopulmonary dysplasia and prematurity in human infants. PLoS One 7(2):e31351
58. Lorenz E, Hallman M, Marttila R, Haataja R, Schwartz DA (2002) Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population. Pediatr Res 52(3):373-376 (Pubitemid 34920267)
59. Ryckman KK, Williams SM, Krohn MA, Simhan HN (2011) Interaction between interleukin-1 receptor 2 and Toll-like receptor 4, and cervical cytokines. J Reprod Immunol 90(2):220-226
60. Barreiro LB, Ben-Ali M, Quach H, Laval G, Patin E, Pickrell JK, Bouchier C, Tichit M, Neyrolles O, Gicquel B, Kidd JR, Kidd KK, Alcaïs A, Ragimbeau J, Pellegrini S, Abel L, Casanova JL, Quintana-Murci L (2009) Evolutionary dynamics of human Toll-like receptors and their different contributions to host defense. PLoS Genet 5(7):e1000562
61. Simhan HN, MacPherson T, Caritis SN, Krohn MA (2008) Maternal and fetal Toll-like receptor 4 genotype and chorionic plate inflammatory lesions. Am J Obstet Gynecol 199(4):400.e1-400.e4
62. Bryant AE, Genc M, Hurtado RM, Chen KT (2004) Pulmonary Kaposi's sarcoma in pregnancy. Am J Perinatol 21(6):355-363 (Pubitemid 39108817)
63. Mockenhaupt FP, Hamann L, von Gaertner C, Bedu-Addo G, von Kleinsorgen C, Schumann RR, Bienzle U (2006) Common polymorphisms of toll-like receptors 4 and 9 are associated with the clinical manifestation of malaria during pregnancy. J Infect Dis 194(2):184-188 (Pubitemid 44087189)
64. Goepfert AR, Varner M, Ward K, Macpherson C, Klebanoff M, Goldenberg RL, Mercer B, Meis P, Iams J, Moawad A, Carey JC, Leveno K, Wapner R, Caritis SN, Miodovnik M, Sorokin Y, O'Sullivan MJ, Van Dorsten JP, Langer O; NICHD Maternal-Fetal Medicine Units Network (2005) Differences in inflammatory cytokine and Toll-like receptor genes and bacterial vaginosis in pregnancy. Am J Obstet Gynecol 193(4):1478-1485 (Pubitemid 41395120)
65. Roszak A, Lianeri M, Sowińska A, Jagodziński PP (2012) Involvement of Toll-like Receptor 9 polymorphism in cervical cancer development. Mol Biol Rep 39(8):8425-8430
66. Ricci E, Malacrida S, Zanchetta M, Mosconi I, Montagna M, Giaquinto C, De Rossi A (2010) Toll-like receptor 9 polymorphisms influence mother-to-child transmission of human immunodeficiency virus type 1. J Transl Med 8:49